Literature DB >> 19941252

Diagnostic features of real-time contrast-enhanced ultrasound in focal nodular hyperplasia of the liver.

F Piscaglia1, A Venturi, M Mancini, F Giangregorio, G Vidili, F Magnolfi, M Mirarchi, F Fornari, L Bolondi.   

Abstract

PURPOSE: The typical appearance of focal nodular hyperplasia (FNH) in radiological contrast techniques (helical CT or MRI) includes homogeneous enhancement in the arterial phase, but the exact timing for the best visualization of this pattern is unknown. The aim of the present study was to assess the ultrasound pattern of FNH with special attention to real-time contrast-enhanced ultrasonography (CEUS) appearance and specifically to the timing of perfusion patterns.
MATERIALS AND METHODS: 72 patients (60 females, 12 males) with a total of 90 FNH nodules with a diameter ranging from 8 to 100 mm (mean +/- SD, 40.6 +/- 21.5 mm) were examined continuously for at least 4 minutes using CnTI and CPS methods (ESAOTE, Genoa, Italy and Acuson-Siemens) after bolus injection of SonoVue (BRACCO, Milan, Italy).
RESULTS: 87 of 90 nodules showed the typical coin-like hyperechogenicity in the arterial phase. The remaining three nodules were all in the same patient and were diagnosed as FNH after resection. Contrast started to appear within the lesions after a mean of 15.7 +/- 4.6 seconds (range 7 - 27 s) and reached peak signal intensity, with the greatest differentiation between the lesion and the surrounding parenchyma, at around 22.6 +/- 7.0 seconds (range 14 - 72 s). In the late phase, 65 lesions (72.2 %) became isoechoic (after a mean of 80.8 +/- 85.7 s, range 20 - 300 s), 22 (24.4 %) slightly hyperechoic and 3 (3.3 %) faintly hypoechoic.
CONCLUSION: FNH shows a typical homogeneous hyperechoic pattern during the arterial phase in real-time CEUS which disappears slowly on average but occasionally even as soon as 20 seconds after contrast injection. If the first scans are taken later than 20 seconds after injection (which is still considered to be a full arterial phase), the ultrasound hyperechogenicity may be missed in some cases. Real-time study of these lesions is therefore strongly recommended to avoid possible false-negative results. Copyright Georg Thieme Verlag KG Stuttgart . New York.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19941252     DOI: 10.1055/s-0028-1109852

Source DB:  PubMed          Journal:  Ultraschall Med        ISSN: 0172-4614            Impact factor:   6.548


  5 in total

1.  Superb microvascular imaging: a potential tool in the detection of FNH.

Authors:  Giovanni Bonacchi; Marco Becciolini; Marta Seghieri
Journal:  J Ultrasound       Date:  2017-02-09

2.  Contrast-enhanced ultrasound features of histologically proven focal nodular hyperplasia: diagnostic performance compared with contrast-enhanced CT.

Authors:  Wei Wang; Li-Da Chen; Ming-De Lu; Guang-Jian Liu; Shun-Li Shen; Zuo-Feng Xu; Xiao-Yan Xie; Yan Wang; Lu-Yao Zhou
Journal:  Eur Radiol       Date:  2013-04-27       Impact factor: 5.315

3.  Focal nodular hyperplasia of the liver after intensive treatment for pediatric cancer: is hematopoietic stem cell transplantation a risk factor?

Authors:  Riccardo Masetti; Carlotta Biagi; Katharina Kleinschmidt; Arcangelo Prete; Federico Baronio; Antonio Colecchia; Davide Festi; Andrea Pession
Journal:  Eur J Pediatr       Date:  2011-01-12       Impact factor: 3.183

Review 4.  Fortuitously discovered liver lesions.

Authors:  Christoph F Dietrich; Malay Sharma; Robert N Gibson; Dagmar Schreiber-Dietrich; Christian Jenssen
Journal:  World J Gastroenterol       Date:  2013-06-07       Impact factor: 5.742

Review 5.  Current consensus and guidelines of contrast enhanced ultrasound for the characterization of focal liver lesions.

Authors:  Jae Young Jang; Moon Young Kim; Soung Won Jeong; Tae Yeob Kim; Seung Up Kim; Sae Hwan Lee; Ki Tae Suk; Soo Young Park; Hyun Young Woo; Sang Gyune Kim; Jeong Heo; Soon Koo Baik; Hong Soo Kim; Won Young Tak
Journal:  Clin Mol Hepatol       Date:  2013-03-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.